Prokidney Corp (PROK) Stock Price, Quote & News

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 336 999 7028

Website: prokidney.com

Address:

2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States

SmartWentCrazy Nov. 14 at 4:10 PM

$PROK

0 · Reply

wavridr Nov. 14 at 2:04 PM

$PROK $2.00 at the bell then down all day again to 1.50 ☠️

0 · Reply

RBLUCKY Nov. 14 at 12:19 AM

$PROK what happened to the stock? Any idea when they may get more results on their trials? What’s the timeframe? I guess their conference was a bust.

0 · Reply

wavridr Nov. 13 at 9:19 PM

$PROK continue this line for 3 more days to $1.00 😂

0 · Reply

SmartWentCrazy Nov. 13 at 8:33 PM

$PROK eat

0 · Reply

Asensus2023 Nov. 13 at 8:09 PM

$PROK its all a game. Dont have weak hands. Stay easy. Wait wait wait. They wanna buy cheap. Go to sleep.

0 · Reply

alanta_clax Nov. 13 at 7:49 PM

$PROK What the hell is happening with this stock? Why are people selling this cheap?

1 · Reply

wavridr Nov. 13 at 7:44 PM

$PROK lmao still hitting new lows 🤣🤣

0 · Reply

wavridr Nov. 13 at 6:05 PM

$PROK look at the 2 day chart. Straight diagonal line going down for 2 days 🤣🤣🤣🤣🤣

0 · Reply

wavridr Nov. 13 at 5:58 PM

$PROK 2.00 EOD let's gooo dump this POS or start shorting it 🔨🔨🔨

0 · Reply

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Nov 6, 2025, 11:00 AM EST - 8 days ago

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

Oct 29, 2025, 7:30 AM EDT - 16 days ago

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Oct 20, 2025, 7:30 AM EDT - 25 days ago

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

Sep 19, 2025, 10:52 AM EDT - 2 months ago

ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy

Sep 8, 2025, 10:14 AM EDT - 2 months ago

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 2:08 PM EDT - 2 months ago

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 27, 2025, 7:30 AM EDT - 2 months ago

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Aug 12, 2025, 4:01 PM EDT - 3 months ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Jul 15, 2025, 7:30 AM EDT - 4 months ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 9, 2025, 11:22 AM EDT - 4 months ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 8:45 AM EDT - 4 months ago

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 7:30 AM EDT - 4 months ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 8, 2025, 5:09 PM EDT - 4 months ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 1:25 PM EDT - 4 months ago

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 9:05 AM EDT - 4 months ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 7:00 AM EDT - 4 months ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 1, 2025, 12:43 PM EDT - 4 months ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

May 12, 2025, 4:15 PM EDT - 6 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 8 months ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Jan 31, 2025, 11:08 AM EST - 10 months ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 6:10 AM EST - 10 months ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Nov 26, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 12, 2024, 7:30 AM EST - 1 year ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 5, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Oct 14, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 9, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

Mar 25, 2024, 6:05 AM EDT - 1 year ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 21, 2024, 7:49 PM EDT - 1 year ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Feb 29, 2024, 4:05 PM EST - 1 year ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Nov 30, 2023, 6:05 AM EST - 2 years ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 21, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 16, 2023, 4:40 PM EST - 2 years ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:05 AM EST - 2 years ago

ProKidney Reports Third Quarter Financial Results

Nov 13, 2023, 5:02 PM EST - 2 years ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Oct 30, 2023, 4:12 PM EDT - 2 years ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Jul 18, 2023, 6:05 AM EDT - 2 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 15, 2023, 2:02 AM EDT - 2 years ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jun 13, 2023, 12:05 PM EDT - 2 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

SmartWentCrazy Nov. 14 at 4:10 PM

$PROK

0 · Reply

wavridr Nov. 14 at 2:04 PM

$PROK $2.00 at the bell then down all day again to 1.50 ☠️

0 · Reply

RBLUCKY Nov. 14 at 12:19 AM

$PROK what happened to the stock? Any idea when they may get more results on their trials? What’s the timeframe? I guess their conference was a bust.

0 · Reply

wavridr Nov. 13 at 9:19 PM

$PROK continue this line for 3 more days to $1.00 😂

0 · Reply

SmartWentCrazy Nov. 13 at 8:33 PM

$PROK eat

0 · Reply

Asensus2023 Nov. 13 at 8:09 PM

$PROK its all a game. Dont have weak hands. Stay easy. Wait wait wait. They wanna buy cheap. Go to sleep.

0 · Reply

alanta_clax Nov. 13 at 7:49 PM

$PROK What the hell is happening with this stock? Why are people selling this cheap?

1 · Reply

wavridr Nov. 13 at 7:44 PM

$PROK lmao still hitting new lows 🤣🤣

0 · Reply

wavridr Nov. 13 at 6:05 PM

$PROK look at the 2 day chart. Straight diagonal line going down for 2 days 🤣🤣🤣🤣🤣

0 · Reply

wavridr Nov. 13 at 5:58 PM

$PROK 2.00 EOD let's gooo dump this POS or start shorting it 🔨🔨🔨

0 · Reply

wavridr Nov. 13 at 4:21 PM

$PROK get on the short bus to $1.00 eventually this POS will sit below 1.00 and RS to take every penny from you 😂

0 · Reply

wavridr Nov. 13 at 2:33 PM

$PROK finally 2.50! Next stop 2.00 🔨🔨🔨

0 · Reply

GJ_Rockabilt Nov. 11 at 4:09 PM

$HUMA , HUMAW : Two Kidney Stocks, $FMS and $PROK are UP, while HUMA & HUMAW are DOWN. Make of this fact, what you will.

0 · Reply

wavridr Nov. 10 at 10:21 PM

$PROK nobody gives a fuk about their earnings 🤣🤣🤣

0 · Reply

AStrokeOfLuck Nov. 10 at 10:06 PM

$PROK

0 · Reply

wavridr Nov. 10 at 8:39 PM

$PROK so many times this is the only POS that's red. Just die already ☠️🪦

0 · Reply

amessagefromtheodd Nov. 8 at 5:03 PM

$PROK ProKidney's Phase 3 clinical study (REGEN-006) for Chronic Kidney Disease (CKD) and type 2 diabetes uses a sham-controlled design, which includes a placebo-like group that receives a sham (fake) procedure instead of the actual cell therapy. This sham control group allows researchers to compare the results of the real treatment against a baseline to determine its safety and effectiveness.

0 · Reply

Biohacker Nov. 7 at 7:08 PM

$PROK what a swing ,not for the faint of heart .

0 · Reply

Asensus2023 Nov. 6 at 5:14 PM

$PROK All positive and only 6 cents plus.

1 · Reply

wavridr Nov. 6 at 5:05 PM

$PROK why is this POS green? EOD dump to 2.50 🔨

0 · Reply

Strizzball Nov. 6 at 4:41 PM

$PROK https://www.quiverquant.com/news/ProKidney+Corp.+Reports+Positive+Phase+2+Results+for+Rilparencel+in+Advanced+Chronic+Kidney+Disease+and+Diabetes

0 · Reply

SmartWentCrazy Nov. 5 at 4:06 PM

$PROK

0 · Reply

Market Cap	788.68M
Revenue (ttm)	80,000.00
Net Income (ttm)	-61.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-76,487.50%
Debt to Equity Ratio	0.00

Volume	1,336,300
Avg Vol	2,198,504
Day's Range	N/A - N/A
Shares Out	294.28M
Stochastic %K	4%
Beta	1.75
Analysts	Sell
Price Target	$5.40